CINXE.COM

Empowering Patients 2025: A Cell and Gene Therapies Summit | ASGCT - American Society of Gene & Cell Therapy

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <!-- Global Site Tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-5483862-1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-5483862-1'); </script> <!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NFW5DS9');</script> <!-- End Google Tag Manager --> <script> //------------------------------------------------------- var z_account = "2632C1D8-6432-4D3A-93D6-08AAECC53F86"; var z_collector = "asgct.informz.net"; var z_cookieDomain = ".asgct.org"; //------------------------------------------------------- (function (e, o, n, r, t, a, s) { e[t] || (e.GlobalSnowplowNamespace = e.GlobalSnowplowNamespace || [], e.GlobalSnowplowNamespace.push(t), e[t] = function () { (e[t].q = e[t].q || []).push(arguments) }, e[t].q = e[t].q || [], a = o.createElement(n), s = o.getElementsByTagName(n)[0], a.async = 1, a.src = r, s.parentNode.insertBefore(a, s)) }(window, document, "script", "https://"+z_collector+"/web_trk/sp.js", "informz_trk")), informz_trk("newTracker", "infz", z_collector + "/web_trk/collector/", { appId: z_account, cookieDomain: z_cookieDomain }), informz_trk("setUserIdFromLocation", "_zs"), informz_trk("enableActivityTracking", 30, 15); informz_trk("trackPageView", null); </script> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width,user-scalable=no,maximum-scale=1.0,initial-scale=1.0"> <link href="/BlueKey/assets/css/app.css" rel="stylesheet"> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:description" content="" /> <meta name="twitter:title" content="" /> <meta name="twitter:site" content="https://twitter.com/ASGCTherapy" /> <meta name="twitter:image" content="https://www.asgct.org/getattachment//attachment.aspx" /> <meta name="twitter:creator" content="@ASGCTherapy" /> <script type="text/javascript" src="//platform-api.sharethis.com/js/sharethis.js#property=5ae883c34d3f70001197fe0b&product=inline-share-buttons"></script> <!-- Hotjar Tracking Code for www.asgct.org --> <script> (function (h, o, t, j, a, r) { h.hj = h.hj || function () { (h.hj.q = h.hj.q || []).push(arguments) }; h._hjSettings = { hjid: 1655159, hjsv: 6 }; a = o.getElementsByTagName('head')[0]; r = o.createElement('script'); r.async = 1; r.src = t + h._hjSettings.hjid + j + h._hjSettings.hjsv; a.appendChild(r); })(window, document, 'https://static.hotjar.com/c/hotjar-', '.js?sv='); </script> <script type="text/javascript"> adroll_adv_id = "LMOGHWAXC5CQHBCHNDJOMB"; adroll_pix_id = "PLJOCPLDXJHPLKUBZAWMIO"; adroll_version = "2.0"; (function(w, d, e, o, a) { w.__adroll_loaded = true; w.adroll = w.adroll || []; w.adroll.f = [ 'setProperties', 'identify', 'track' ]; var roundtripUrl = "https://s.adroll.com/j/" + adroll_adv_id + "/roundtrip.js"; for (a = 0; a < w.adroll.f.length; a++) { w.adroll[w.adroll.f[a]] = w.adroll[w.adroll.f[a]] || (function(n) { return function() { w.adroll.push([ n, arguments ]) } })(w.adroll.f[a]) } e = d.createElement('script'); o = d.getElementsByTagName('script')[0]; e.async = 1; e.src = roundtripUrl; o.parentNode.insertBefore(e, o); })(window, document); adroll.track("pageView"); </script> <script type="text/javascript" defer="defer" src="https://extend.vimeocdn.com/ga/127349852.js"></script><meta charset="UTF-8" /> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="shortcut icon"/> <link href="/App_Themes/Default/Images/favicon.ico" type="image/x-icon" rel="icon"/> <title> Empowering Patients 2025: A Cell and Gene Therapies Summit | ASGCT - American Society of Gene &amp; Cell Therapy </title></head> <body class="LTR IE IE7 ENUS ContentBody ASGCTEventDetail" <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NFW5DS9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> <form method="post" action="/asgct-events/march-2025/empowering-patients-2025-a-cell-and-gene-therapie" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="__CMSCsrfToken" id="__CMSCsrfToken" value="Z/Hq/10+uthP1PELdagDDMHMZcjtXBaFbxSt8hkCPizh5c1fpL/GD7J31UHpuDMRFtZoU7bN9CD9dx1nkIFS9MM1dL8=" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=UZQNzmZXG1IdUaHxtavOjRvGEvOmz1kvw97PqEaxzBy7Ys-tUotw-RqgdbsvC3g_7cXjehqAdA_N6kbuK73WBAVGdxo1&amp;t=638562384440000000" type="text/javascript"></script> <input type="hidden" name="lng" id="lng" value="en-US" /> <script type="text/javascript"> //<![CDATA[ function PM_Postback(param) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); } if(window.CMSContentManager) { CMSContentManager.allowSubmit = true; }; __doPostBack('ctl00$CMSPortalManager1$am',param); } function PM_Callback(param, callback, ctx) { if (window.top.HideScreenLockWarningAndSync) { window.top.HideScreenLockWarningAndSync(1080); }if (window.CMSContentManager) { CMSContentManager.storeContentChangedStatus(); };WebForm_DoCallback('ctl00$CMSPortalManager1$am',param,callback,ctx,null,true); } //]]> </script> <script src="/ScriptResource.axd?d=WTJtoz6EJe-loUBJ9stbRxqzgpVp8oo0KdZGkhGfcu6Lr7kb5LeNfx21FKi8mxEL1oDZOLAxiAqERpClgBx-A6lZ0DJ1qKcDZB1NuIbRd8o9S7aG0&amp;t=7c776dc1" type="text/javascript"></script> <script src="/ScriptResource.axd?d=y6KGkkRaceYF_mkApXCXMQ_rMQVX59BlJ-ut-lQDHw88bR5bbS86epdVNwimj01duE6_OophLX4sBTOgb8_5dNLaY2Mx5DHMJj7Rbr4kPMV1-AOS5VF5-QEC8oG-_-aHoWoyqA2&amp;t=7c776dc1" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var CMS = CMS || {}; CMS.Application = { "isDialog": false, "isDebuggingEnabled": false, "applicationUrl": "/", "isRTL": "false", "imagesUrl": "/CMSPages/GetResource.ashx?image=%5bImages.zip%5d%2f" }; //]]> </script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="3CF69206" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAQlcIFkJuAUPAGlimOt5lkcWc/UGC0MiqcU6HCwvNVJvgzDekAIswc+CqD21He/aAGQ9TUHX5f3Frmq+VYe3Rj03F3k6KGgoae45LlKdKe48gJh1wc=" /> </div> <script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$manScript', 'aspnetForm', ['tctl00$ctxM',''], [], [], 90, 'ctl00'); //]]> </script> <div id="ctl00_ctxM"> </div> <div class="wide"> <header> <div class="container"> <div class="logo"><a href="/"><img src="/BlueKey/assets/images/logo.png" alt="American Society of Gene and Cell Therapy"></a></div> <div class="topSearchWrapper"> <div class="topSearch"> <input type="text" placeholder="Enter Search Text Here"> <input type="submit" value="Go"> </div> <div class="topSearchToggle"></div> </div> <div class="topLinks"> <ul> <li><a href="/contact">Contact Us</a></li> </ul> </div> <div class="socialLinks topSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div> <div class="topActions"> <input type="submit" name="ctl00$bkSiteHeader$logoutButton$btnSignOut" value="Member Login" id="ctl00_bkSiteHeader_logoutButton_btnSignOut" class="signoutButton btn btn-accent3 ghost btn-default" /> </div> <div class="menuToggle"></div> </div> <div id="ctl00_bkSiteHeader_headerBanner"> <div class="header-alert"> <div class="container"> <p><b><a href="https://annualmeeting.asgct.org/abstracts">Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!</a></b></p> </div> </div> </div> <div class="navShade"></div> <div class="mainNav"> <div class="container"> <ul id="cmsMainNav" class="CMSListMenuUL"> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/annual-meeting">Annual Meeting</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/registration">Register</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/sponsor-exhibit">Sponsor & Exhibit</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/future-annual-meetings">Future Annual Meetings</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/annual-meeting-archives">Annual Meeting Archives</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/program">Program</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/workshops">Workshops</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/program/schedule-at-a-glance">Venue Maps</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/annual-meeting/abstracts">Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/present">Present</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/awards">Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/annual-meeting/abstracts/topics">Topics</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/membership">Membership</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/video-library">Video Library</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/annual-meeting">Annual Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/cancer">Cancer</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/career-skills">Career Skills</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/gene-editing">Gene Editing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/patients-and-clinicians">Patients and Clinicians</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/regulatory">Regulatory</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/video-library/aav">Viral Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/become-a-member">Become a Member</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/economy-based-rates">Economy-Based Rates</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/grants-awards">Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/membership-directory-new">Membership Directory</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/standing-committees">Standing Committees</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/my-profile">My Profile</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href=" http://jobs.asgct.org/" target="_blank">Career Center</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/submit-an-abstract">ASGCT Abstracts</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/membership/submit-an-abstract/asgct-abstract-submission-windows">Abstract Submission Windows</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/membership/volunteer">Volunteer</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/events">Events</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/around-the-world-advanced-therapy-medicinal-produc">Around the World: Advanced Therapy Medicinal Production in South America</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/molecular-therapy-presents-extracellular-vesicles">Molecular Therapy Presents: Extracellular Vesicles</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/empowering-patients-2025-a-cell-and-gene-therapies">Empowering Patients 2025: A Cell and Gene Therapies Summit</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/non-asgct-events">Non-ASGCT Events</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/breakthroughs-in-muscular-dystrophy">Breakthroughs in Muscular Dystrophy</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/registration">Registration</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/abstracts">Abstracts</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/program">Program</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/speaker-and-attendee-resources">Speaker + Attendee Resources</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/breakthroughs-in-muscular-dystrophy/sponsorship">Sponsorship</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/class-considerations-on-immunogenicity-for-aav-gen">Class Considerations on Immunogenicity for AAV GT Products: Assessing Current Practice + New Data</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/events/career-development-seminars">Professional Development Cafés</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/events/career-development-seminars/focused-ultrasound-cutting-edge-applications-in-ce">Dec. 13: Focused Ultrasound: Cutting-Edge Applications in Cell and Gene Therapies</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/awards">Awards</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/honorific-awards">Honorific Awards</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-achievement-award">Outstanding Achievement Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/outstanding-new-investigator-awards">Outstanding New Investigator Awards</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/george-stamatoyannopoulos-mentorship-award">George Stamatoyannopoulos Mentorship Award</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/excellence-advancing-diversity-equity-inclusion">Award for Excellence in Advancing Diversity, Equity, and Inclusion</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/awards/honorific-awards/exemplary-service-award">Exemplary Service Award</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/career-development-awards">Career Development Awards</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/congressional-policy-fellowship">Congressional Policy Fellowship</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/underrepresented-populations-fellowship">Underrepresented Populations in Gene and Cell Therapy</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/awards/mavis-agbandje-mckenna-scholarship-and-fund">Mavis Agbandje-McKenna Scholarship and Fund</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/education">Outreach</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/clinicaltrials">Clinical Trials Finder</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/lunch-learn-events">Community Quick Takes</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/informed-consent">Informed Consent</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/state-of-the-field-highlights-approvals-for-cgt">State of the Field Highlights + Approvals for CGT in 2023</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/access-to-approved-cell-and-gene-therapies">Access to Approved Cell and Gene Therapies</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/lunch-learn-events/genetic-testing-and-clinical-trial-eligibility">Genetic Testing and Clinical Trial Eligibility</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/diversity-equity-and-inclusion-mission-goals">Diversity, Equity, and Inclusion</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/diversity-equity-and-inclusion-mission-goals/biotech-discovery-labs-program">Biotech Discovery Labs Program</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/gene-therapy-101">Patient Education: Gene Therapy 101</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-basics">Gene Therapy Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-therapy-approaches">Gene Therapy Approaches</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/developing-a-treatment">Clinical Trials Process</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/vectors-101">Vectors 101</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/gene-therapy-101/gene-editing">Gene Editing</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/global-outreach">Global Outreach</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/education/disease-treatments">Patient Education: Condition Treatments</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/beta-thalassemia-other-blood-disorders">Beta Thalassemia & Other Blood Disorders</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/leukodystrophy">CALD and MLD</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/spinal-muscular-atrophy">Spinal Muscular Atrophy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/blood-cancers-car-t-cell-therapy">CAR-T Basics</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/education/disease-treatments/hemophilia-gene-therapy">Hemophilia</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/publications">Publications</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/news">ASGCT Blog</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-patient-press">The Patient Press</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-patient-press/october-2024">October 2024</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-vector">The Vector</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/landscape-report">Quarterly Gene, Cell, and RNA Therapy Landscape Report</a></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/asgct-podcast-network">ASGCT Podcast Network</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/giants-of-gene-therapy">Giants of Gene Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-issue">The Issue</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/asgct-podcast-network/the-molecular-therapy-podcast">The Molecular Therapy Podcast</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/publications/molecular-therapy">Molecular Therapy Family</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy-presents-targets-and-biomarkers">Molecular Therapy Presents Extracellular Vesicles</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/cell-press-webinar-advances-in-viral-vector-gene-d">Cell Press Webinar: Advances in Viral Vector Gene Delivery for CT Biomanufacturing</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/molecular-therapy">Molecular Therapy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt–methods-clinical-development">MT Methods & Clinical Development</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt–nucleic-acids">MT Nucleic Acids</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/publications/molecular-therapy/mt–oncolytics">MT Oncology</a></li></ul></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/advocacy">Advocacy</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/events-and-opportunities">Events and Opportunities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/policy-summit">Policy Summit</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/asgct-fda-liaison-meeting-(1)">ASGCT-FDA Liaison Meeting</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/cgt-science-series">Cell + Gene Therapy Science Series</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/congressional-policy-fellowship">Congressional Policy Fellowship</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/events-and-opportunities/fda-immune-responses-aav-vectors">FDA & ASGCT: Immune Responses to AAV Vectors</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-priorities">Policy Priorities</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/patient-access-overview">Patient Access Overview</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/regulatory-policy">Regulatory Policy</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/policy-priorities/research-funding">Research Funding</a></li></ul></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/the-advocate">The Advocate</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/advocacy/the-advocate/subscribe-to-the-advocate">Subscribe to The Advocate</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/advocacy/policy-statements-letters">Policy Statements & Letters</a></li></ul> </div> </li> <li class="CMSListMenuLIhasChildren"> <a class="CMSListMenuLink" href="/about">About</a> <div class="menu-wrap"> <ul id="column1" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/leadership">Leadership</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/board-officers">Board of Directors</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/scientific-committees">Scientific Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/standing-committees">Standing Committees</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/leadership/staff">Staff</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/careers">Work at ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/development-coordinator">Development Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/education-coordinator">Education Coordinator</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/careers/meeting-planner">Meeting Planner</a></li></ul></li></ul> <ul id="column2" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/media">Media</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/culture">Our Culture</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/strategic-plan">Strategic Plan</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/meeting-code-of-conduct">Meeting Code of Conduct</a></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/terms-and-conditions">Terms and Conditions</a></li></ul> <ul id="column3" style="display: block;"><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/mission-vision">Mission & Vision</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/mission-vision/bylaws">Bylaws</a></li></ul></li><li class="CMSListMenuLI"><a class="CMSListMenuLink is-link-large" href="/about/support">Support ASGCT</a><ul class="CMSListMenuUL-GRANDCHILD" style="display: block;"><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/annual-meeting-support">Annual Meeting Support</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/advertise-asgct-publications">Advertise in ASGCT Publications</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/support-asgct-s-digital-programs">Digital Programs</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/giving">Giving</a></li><li class="CMSListMenuLI-GRANDCHILD"><a class="CMSListMenuA-GRANDCHILD" href="/about/support/year-round-support">Year-Round Support</a></li></ul></li></ul> </div> </li> </ul> </div> <div class="mainNavClose"></div> </div> </header> <div class="masthead"> <div class="container"></div> </div> <section class="mainBody"> <div class="container"> <main> <div id="ctl00_plcMain_pnlEventCategory"> <p class="event-detail__eyebrow">Outreach</p> </div> <h1>Empowering Patients 2025: A Cell and Gene Therapies Summit </h1> <div id="ctl00_plcMain_pnlEventTitleTime"> <h2 class="event-detail__subtitle">March 12 - 13, 2025</h2> </div> <hr> <div id="ctl00_plcMain_pnlEventDesc"> <p><p>This inaugural virtual event&nbsp;<strong>March 12 and 13, 2025&nbsp;(9 a.m. - 12:30 p.m. ET</strong> on both days), will provide timely education and engaging discussions on cell and gene therapies (CGTs). In alignment with ASGCT&rsquo;s <a aria-label="Link strategic plan" href="https://www.asgct.org/about/strategic-plan" id="menur5df" rel="noreferrer noopener" target="_blank" title="https://www.asgct.org/about/strategic-plan">strategic plan</a>, the goal is to empower advocates, patients, and caregivers who are vital in developing treatments. Attendees will hear from experts in the CGT field, as well as patient advocacy group leaders. There will be opportunities to ask questions and deepen your knowledge of the community&rsquo;s CGT journey.</p> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{124}" paraid="1212032025">In advance of the Summit, visit ASGCT&rsquo;s resources on the <a href="https://patienteducation.asgct.org/" rel="noreferrer noopener" target="_blank">Patient Education</a><a href="https://patienteducation.asgct.org/" target="_blank"> </a>website and <a href="https://asgct.informz.net/asgct/pages/Patient_Press_Signup" rel="noreferrer noopener" target="_blank">subscribe</a> to <a href="/publications/the-patient-press" rel="noreferrer noopener" target="_blank">The Patient Press</a>, to stay up to date on latest events, resources, and news relevant to the patient community.&nbsp;</p> <h2 paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{132}" paraid="4">Agenda</h2> <h3 paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{132}" paraid="4">March 12, 2025</h3> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{146}" paraid="8"><strong>Partners in Progress: The Value of Patients and Advocates&nbsp;</strong><br /> 9 &ndash; 9:15 a.m.&nbsp;</p> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{162}" paraid="11">The opening address will spotlight the important role patients, caregivers, and advocates have in advancing CGTs for rare diseases and disorders.&nbsp;&nbsp;</p> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{198}" paraid="12"><strong>Intro to Gene Therapy Approaches&nbsp;</strong><br /> 9:15 &ndash; 9:45 a.m.&nbsp;</p> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{210}" paraid="14">This session will review the science behind some common <a href="https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-approaches" rel="noreferrer noopener" target="_blank">treatment approaches</a><a href="https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-approaches" target="_blank"> </a>(Gene addition, gene editing, CAR-T, RNA, ASO), along with the unique risks, challenges, and potential benefits of CGTs.&nbsp;&nbsp;</p> <p paraeid="{f6ea09d6-5abd-408c-a68b-784aee58f9a5}{248}" paraid="20"><strong>Why Are Clinical Trials for Rare Diseases Different?&nbsp;&nbsp;</strong><br /> 9:45 &ndash; 10:15 a.m.&nbsp;</p> <p paraeid="{087c6b9c-255f-4d4d-b3b3-320a907a109a}{5}" paraid="23">There are important considerations for any person thinking of participating in an experimental <a href="https://patienteducation.asgct.org/gene-therapy-101/clinical-trials-process" rel="noreferrer noopener" target="_blank">CGT trial</a>, especially for those with limited time and treatment options. This talk will introduce the clinical development pipeline, from pre-clinical studies all the way to FDA approval.&nbsp; Dive into learning how CGT trials differ from the traditional drug development framework.&nbsp;&nbsp;&nbsp;</p> <p paraeid="{087c6b9c-255f-4d4d-b3b3-320a907a109a}{93}" paraid="30"><strong>Complexity of Study Design in Cell and Gene Therapy&nbsp;</strong><br /> 10:25 - 11:25 a.m.&nbsp;&nbsp;</p> <p paraeid="{087c6b9c-255f-4d4d-b3b3-320a907a109a}{107}" paraid="1005526350">The research team makes several complex decisions when designing a clinical trial including, but not limited to, determining eligibility, dosage, and the use of placebo or external controls. This session will feature a thoughtful discussion with clinical trial experts to illuminate how clinicians make those decisions and their impact on potential participants.&nbsp;&nbsp;</p> <p paraeid="{087c6b9c-255f-4d4d-b3b3-320a907a109a}{239}" paraid="46"><strong>When Innovation Stumbles + Pathways Forward&nbsp;</strong><br /> 11:30 a.m.&nbsp;- 12:25 p.m.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{6}" paraid="211463111">This session will explore the state of commercially pre-viable therapies (sometimes referred to as dropped or discontinued trials). We will hear both a clinician&rsquo;s take on why this happens and potential solutions, and from a patient advocate who has dealt with this challenge.&nbsp;&nbsp;</p> <p paraeid="{fbeda37c-00c5-4a03-b166-f98a7fcba761}{36}" paraid="1798819912"><strong>Closing Remarks&nbsp;</strong></p> <h3 paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{16}" paraid="58">March 13, 2025</h3> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{26}" paraid="148427486"><strong>Morning Coffee with Dr. Peter Marks</strong><br /> 9:05 - 9:50 a.m.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{38}" paraid="67">This live sit-down with FDA&nbsp;leadership will share insights on Agency efforts for rare disease drug development. The discussion will touch on patient experience data for regulatory pathways, the new Rare Disease Innovation Hub, expedited pathways, and more.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{98}" paraid="74"><strong>Developing Gene Therapies as Platform Technologies&nbsp;</strong><br /> 9:55 - 10:25 a.m.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{116}" paraid="77">This session will dive into the concept of platform technologies to streamline CGT development. Speakers will explain how platforms work in CGTs and how public-private partnerships are helping to lay the tracks for developers to use.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{196}" paraid="81"><strong>The Journey from Early-stage Trials to Approval&nbsp;&nbsp;</strong><br /> 10:40 - 11:45 a.m.&nbsp;</p> <p paraeid="{b98ac816-3d92-4f56-b216-35e77e08a312}{224}" paraid="82">In this live panel discussion, we&rsquo;ll hear from patient advocate leaders in varying disease areas who are at different points in the CGT journey. The discussion will span funding first research initiatives, through approaching a CGT approval. Panelists will share their experiences and insights on how to overcome potential obstacles along the road to treatment.&nbsp;&nbsp;&nbsp;</p> <p paraeid="{8debec92-1be4-45bb-89a7-38ad4cf270a5}{19}" paraid="95"><strong>Exploring Goals of Care and Personal Values when Considering CGT Trials&nbsp;</strong><br /> 11:50 a.m.&nbsp;- 12:20 p.m.&nbsp;</p> <p paraeid="{8debec92-1be4-45bb-89a7-38ad4cf270a5}{63}" paraid="102">It is important to manage participant and family expectations for any potential CGT clinical trial. Patients, caregivers, clinicians, and advocates often must engage in challenging discussions when considering an investigational treatment. This talk will outline some of those common dilemmas and offer advice to help navigate difficult conversations.&nbsp;&nbsp;</p> <p paraeid="{dc7cdb18-64fa-479f-b40a-4ecd58aa29cf}{109}" paraid="33467604"><strong>Closing Remarks&nbsp;&nbsp;</strong></p> </p> </div> </main> <aside> <div class="asideBox"> <div class="event-detail-sidebar-content"> <div id="ctl00_plcMain_pnlEventButtonLink"> <p><a style="text-decoration: none;" class="btn btn-accent3" target="_blank" href="https://www.asgct.org/events-registration?EventKey=EP_Mar2025">Register</a></p> </div> <div id="ctl00_plcMain_pnlEventStartTime"> <p class="event-detail-date"><span>Start Time</span>03/12/2025 08:00 AM</p> </div> <div id="ctl00_plcMain_pnlEventEndTime"> <p class="event-detail-time"><span>End Time</span>03/13/2025 11:30 AM</p> </div> <div id="ctl00_plcMain_pnlEventVenue"> <p class="event-detail-venue"><span>Venue</span>Virtual</p> </div> <div id="ctl00_plcMain_pnlEventMemberPrice"> <p class="event-detail-venue"><span>Member Price</span>FREE</p> </div> <div id="ctl00_plcMain_pnlEventNonMemberPrice"> <p class="event-detail-venue"><span>Non-Member Price</span>FREE</p> </div> </div> </div> </aside> </div> </section> <div class="event-row"> <div class="year">2025</div> <div class="content"> <h2>Class Considerations on Immunogenicity for AAV GT Products</h2> <p>January 22-23, 2025 | Virtual</p> </div> <div class="action"><a class="btn btn-white" href="https://www.asgct.org/asgct-events/january-2025/class-considerations-on-immunogenicity-for-aav-gen">Learn More</a></div> </div> <footer> <div class="container"> <div class="footerColContainer"> <div class="footerCol"> <p><img alt="logo-footer.png" class="footerLogo" src="/getmedia/c77b7df1-12a2-4998-9809-0a880c107341/ASGCT_Web_Horz_White.aspx" title="logo-footer.png" /></p> <p>20800 Swenson Dr.<br /> Suite 300<br /> Waukesha, WI 53186</p> </div> <div class="footerCol"> <ul> <li><a href="/about">About</a></li> <li><a href="/membership">Membership</a></li> <li><a href="https://annualmeeting.asgct.org" target="_blank">Annual Meeting</a></li> <li><a href="http://www.cell.com/molecular-therapy-family/home" target="_blank">Journal</a></li> </ul> </div> <div class="footerCol"> <ul> <li><a href="/education">Education</a></li> <li><a href="/advocacy">Advocacy</a></li> <li><a href="https://asgct.org/awards" target="_blank">Awards</a></li> <li><a href="https://asgct.org/about/privacy-policy" target="_blank">Privacy Policy</a></li> </ul> </div> <div class="footerCol"> <p class="altStyle">Connect with ASGCT</p> <p><strong>Phone:</strong> 414.278.1341<br /> <a href="mailto:info@asgct.org">info@asgct.org</a><div class="footerSocial"><div id="ctl00_bkSiteFooter_rptFooterBlocks_ctl04_widget1_ctl00_divSocialLinks" class="socialLinks footerSocial"> <ul> <li><a href="https://twitter.com/ASGCTherapy" target="_blank"><i class="bk-icon-twitter"></i></a></li> <li><a href="https://www.facebook.com/asgctherapy" target="_blank"><i class="bk-icon-facebook"></i></a></li> <li><a href="https://www.instagram.com/asgctherapy" target="_blank"><i class="bk-icon-instagram"></i></a></li> <li><a href="https://www.youtube.com/user/ASGCT" target="_blank"><i class="bk-icon-youtube"></i></a></li> <li><a href="https://www.linkedin.com/company/asgct/" target="_blank"><i class="bk-icon-linkedin"></i></a></li> </ul> </div></div></p> </div> </div> </div> </footer> <div class="postFooter"> <div class="container"> <p>&copy; 2000-2024 All rights reserved. American Society of Gene &amp; Cell Therapy.&nbsp;</p> <p class="bkCredit"><a href="https://www.reasononeinc.com/kentico" title="BlueKey is a Full Service Digital Agency and Kentico Gold Partner. Click to learn more about our Kentico development services" target="_blank">Kentico CMS Development by Reason One</a> | <a href="http://www.kentico.com" target="_blank">Powered by Kentico</a></p> </div> </div> <div class="CookieConsent"> <span id="ctl00_cookieLawQ_lblText" class="ConsentText">This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.</span> <span class="ConsentButtons"> <input type="submit" name="ctl00$cookieLawQ$btnAllowSpecific" value="OPT OUT" id="ctl00_cookieLawQ_btnAllowSpecific" class="ConsentButton btn btn-default" /> <input type="submit" name="ctl00$cookieLawQ$btnAllowAll" value="ACCEPT" id="ctl00_cookieLawQ_btnAllowAll" class="ConsentButton btn btn-default" /> </span> </div> <script src="/BlueKey/assets/js/app-dist.js"></script> <script src="/BlueKey/assets/js/timeline-dist.js"></script> </div> <script type="text/javascript"> //<![CDATA[ var callBackFrameUrl='/WebResource.axd?d=nNME_ObE2oIDm535eYM9xWmIMy-HXBVdo54Ly6sA5tAYPS1aA-gFDzodlP9ijTBRgmjStONrH4-ISuRTp7slHiYkACw1&t=638562384440000000'; WebForm_InitCallback();//]]> </script> </form> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10